BCAL Diagnostics Limited
BDX
Rank in Stocks
#27360
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Share Price
$0.04067041
Last synced: 2026-11-16
Market Cap
$14.99M
Change (1 day)
-0.39%
Change (1 year)
-28.04%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BCAL Diagnostics Limited (BDX)
Category
Healthcare
Operating Margin for BCAL Diagnostics Limited (BDX)
Operating Margin as of November 2026 TTM: -5,145.88%
According to BCAL Diagnostics Limited's latest financial reports, its current operating margin (TTM) is -5,145.88%. At the end of 2025 the company had an operating margin of -46,043.03%.
Operating Margin history for BCAL Diagnostics Limited from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -5,145.88% | -88.82% |
| 2025 | -46,043.03% | 26,087.60% |
| 2024 | -175.82% | 4.98% |
| 2023 | -167.48% | -60.24% |
| 2022 | -421.26% | -35.59% |
| 2021 | -654.03% | 153.98% |
| 2020 | -257.51% | -2.65% |
| 2019 | -264.52% | -9.00% |
| 2018 | -290.68% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -100.00% |
US
|
|
| 20.38% | -100.00% |
US
|
|
| 43.02% | -100.01% |
CN
|
|
| 32.30% | -100.01% |
US
|
|
| 22.23% | -100.00% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about BCAL Diagnostics Limited's operating margin
What is BCAL Diagnostics Limited's operating margin?
BCAL Diagnostics Limited's operating margin is -5,145.88%, as of Nov 2026.
What was BCAL Diagnostics Limited's operating margin in 2025?
In 2025, BCAL Diagnostics Limited's operating margin was -46,043.03%, compared with -175.82% in 2024.
How has BCAL Diagnostics Limited's operating margin changed since 2020?
From 2020 to 2025, BCAL Diagnostics Limited's operating margin was highest in 2023 (-167.48%) and lowest in 2025 (-46,043.03%).
How does BCAL Diagnostics Limited's operating margin compare with similar companies?
BCAL Diagnostics Limited's operating margin (-5,145.88%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.